Nucleo Life Sciences Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

Nucleo Life Sciences General Information

Description

Developer of pharmaceutical products intended to help patients by developing innovative therapies into commercially viable products. The company offers pre-formulation and formulation development, process development, analytical development, method transfer as well as scale-up services, enabling its clients to take their drugs to the market quickly and effectively.

Contact Information

Website
www.nucleolifesciences.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
CoreRx
Primary Office
  • 27 Jordan Street
  • San Rafael, CA 94901
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nucleo Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nucleo Life Sciences‘s full profile, request access.

Request a free trial

Nucleo Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical products intended to help patients by developing innovative therapies into commercially viab
Drug Discovery
San Rafael, CA
13 As of 2021
000000000000

000000

, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dol
000000000000000
Mumbai, India
00000 As of 0000
00000
000000000 00000

000000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000000000000
Basel, Switzerland
00 As of 0000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nucleo Life Sciences Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glenmark Pharmaceuticals Corporation Mumbai, India 00000 00000 000000000 00000
0000000 Corporate Backed or Acquired Basel, Switzerland 00 000000&0
000000 Private Equity-Backed Cambridge, United Kingdom 000 0000 000000000 0000
00000000 00000000 Corporate Backed or Acquired College Station, TX 0000 0000000000
00000 Corporation Mumbai, India 00000 0&0
You’re viewing 5 of 22 competitors. Get the full list »

Nucleo Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nucleo Life Sciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nucleo Life Sciences‘s full profile, request access.

Request a free trial